# Automated active learning to optimize hydrogel drug release profiles

**Authors:** Eugene Cheong, D. Christopher Radford, Adam J. Gormley

PMC · DOI: 10.1016/j.jconrel.2026.114602 · Journal of controlled release : official journal of the Controlled Release Society · 2026-03-23

## TL;DR

This paper introduces an automated machine learning system to optimize hydrogel drug release, reducing the need for extensive experiments.

## Contribution

The novel contribution is an ML-guided framework combining automation and Bayesian optimization for efficient hydrogel formulation.

## Key findings

- A Gaussian process model predicted drug release profiles using features like time and alginate properties.
- Bayesian optimization achieved near-zero-order release of BSA and chABC-SENs with minimal iterations.
- The system successfully translated optimized BSA formulations to chondroitinase ABC delivery without further adjustments.

## Abstract

Hydrogels are widely used in drug delivery due to their biocompatibility and tunable release properties. However, optimizing hydrogel formulations to the desired release of therapeutics remains experimentally intensive. In this study, we developed an automated, high-throughput and machine learning (ML)-guided framework to efficiently optimize alginate formulations for drug delivery. Using a liquid handling robot, we initially prepared a diverse seed library of 120 alginate hydrogel formulations loaded with bovine serum albumin (BSA) and measured their release profiles. A Gaussian process regression (GPR) ML model was trained to predict cumulative release across time, enabling implicit modeling of release curves. Feature importance analysis using Shapley additive explanations (SHAP) identified time, alginate molecular weight, and concentration as dominant factors influencing release kinetics. Through Bayesian optimization and active learning, we iteratively selected and tested new formulations, progressively reaching a near zero-order release. Finally, the top-performing BSA-optimized formulations were directly applied to the sustained release of chondroitinase ABC single-enzyme nanoparticles (chABC-SENs), achieving near-zero-order release with no further optimizations. This study demonstrates a scalable, data-driven strategy for hydrogel formulation optimization and highlights the potential of ML to accelerate the development of controlled release systems for sensitive and valuable therapeutics.

## Linked entities

- **Chemicals:** alginate (PubChem CID 5102882)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Chemicals:** alginate (MESH:D000464), chABC (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13007785/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13007785/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC13007785/full.md

---
Source: https://tomesphere.com/paper/PMC13007785